Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Goodwill (2016 - 2025)

Historic Goodwill for Myriad Genetics (MYGN) over the last 15 years, with Q3 2025 value amounting to $51.6 million.

  • Myriad Genetics' Goodwill fell 8197.69% to $51.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.6 million, marking a year-over-year decrease of 8197.69%. This contributed to the annual value of $286.3 million for FY2024, which is 38.27% down from last year.
  • Per Myriad Genetics' latest filing, its Goodwill stood at $51.6 million for Q3 2025, which was down 8197.69% from $51.6 million recorded in Q2 2025.
  • Over the past 5 years, Myriad Genetics' Goodwill peaked at $328.3 million during Q1 2021, and registered a low of $51.6 million during Q2 2025.
  • Its 5-year average for Goodwill is $249.0 million, with a median of $286.3 million in 2024.
  • Its Goodwill has fluctuated over the past 5 years, first skyrocketed by 2118.39% in 2023, then crashed by 8197.69% in 2025.
  • Over the past 5 years, Myriad Genetics' Goodwill (Quarter) stood at $239.2 million in 2021, then increased by 19.9% to $286.8 million in 2022, then rose by 0.21% to $287.4 million in 2023, then fell by 0.38% to $286.3 million in 2024, then crashed by 81.98% to $51.6 million in 2025.
  • Its Goodwill stands at $51.6 million for Q3 2025, versus $51.6 million for Q2 2025 and $286.3 million for Q1 2025.